Sarilumab: a new IL ‐6 receptor blocker for rheumatoid arthritis

This article examines its indications, efficacy and adverse effects.

Source: Prescriber - November 20, 2017 Category: Primary Care Authors: Steve Chaplin Tags: New Product Source Type: research